Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells https://www.biorxiv.org/content/10.1101/2023.05.22.541831v1?med=mas
Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells https://www.biorxiv.org/content/10.1101/2023.05.22.541831v1?med=mas